The infection control market is projected to reach USD 58.3 billion by 2027 from USD 50.0 billion in 2022, at a CAGR of 3.1% during the forecast period. Growth in this market is majorly driven by the high incidence of hospital-acquired infections (HAIs), increasing number of surgical procedures, growing geriatric population, the increasing incidence of chronic diseases, technological advancements in sterilization equipment, and growing focus on food sterilization and disinfection.
The global infection control market is highly fragmented and competitive, with various players governing major shares in the sterilization, disinfection, and endoscope reprocessing markets. The prominent players in infection control market are Steris Plc (US), Getinge AB (Sweden), Ecolab, Inc. (US), 3M Company (US), Belimed AG (Switzerland), Metrex Research LLC (US), Sotera Health Company (US), MMM Group (Germany), Matachana Group (Spain), The Miele Group (Germany), Systec GmbH (Germany), Contec, Inc.(US), Continental Equipment Company (US), MEDALKAN (Greece), C.B.M. S.R.L. Medical Equipment (Italy), and Spire Integrated Solutions (US).
To know about the assumptions considered for the study download the pdf brochure
STERIS plc focuses on infection prevention and markets an array of products and services, including microbial reduction of medical devices, dental instruments and tools, laboratory testing services, outsourced reprocessing, automated endoscope reprocesses, contract processing services using gamma irradiation, electron beam processing, and EtO technologies. The company has a strong geographic presence across North America, Latin America, Europe, Asia, and the Middle East & Africa and it markets its infection control products through all the business divisions. In 2021, STERIS’ revenue increased to USD 4,585.1 million for the year ended March 31, 2022, compared to USD 3,107.5 million for the year ended March 31, 2021.
Getinge AB specializes in offering products and solutions for operating rooms, intensive care units and sterilization departments. It holds a significant market position in both the sterilization products & services and disinfectants markets. The company’s Life Sciences segment offers a comprehensive range of equipment, technical expertise, and consultation services to prevent contamination in biopharmaceutical production, biomedical research, medical device manufacturing, and laboratory applications. The company focuses on organic and inorganic strategies, such as product launches, expansions, partnership, and acquisitions and derives most of its revenue from the developed regions of North America and Europe.
Infection Control Market by Product (Sterilization (Dry Heat, Radiation, Hydrogen Peroxide, EtO), Disinfection (Wipes, Spray, Disinfectors), Protective Barriers, Endoscopic Reprocessing], End User (Medical Device, Hospitals) - Global Forecast to 2027
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE